Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROTHENA CORP PUBLIC LTD CO Director's Dealing 2015

Nov 25, 2015

32782_dirs_2015-11-25_4531b674-3b46-44fa-9f79-db1dd3fd4757.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2015-11-25

Reporting Person: Ekman Lars (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-25 Ordinary Shares, par value $0.01 per share M 30000 $6.41 Acquired 30243 Direct
2015-11-25 Ordinary Shares, par value $0.01 per share S 16588 $72.9602 Disposed 13655 Direct
2015-11-25 Ordinary Shares, par value $0.01 per share S 11502 $73.7262 Disposed 2153 Direct
2015-11-25 Ordinary Shares, par value $0.01 per share S 1910 $74.4349 Disposed 243 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-25 Stock Option (right to buy) $6.41 M 30000 Disposed 2023-01-29 Ordinary Shares (30000) Direct

Footnotes

F1: The transaction was executed in multiple trades in prices ranging from $72.28 to $73.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F2: The transaction was executed in multiple trades in prices ranging from $73.28 to $74.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F3: The transaction was executed in multiple trades in prices ranging from $74.28 to $74.715, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F4: The shares underlying the option are fully vested exercisable as of the date hereof.